no link between fertility drugs and breast, ovarian and uterine cancers
Many women undergoing fertility treatments have concern that these extra doses of hormones might set the stage for future health risks such as cancer. Results of a 30-year study addressing this very topic were presented at the annual meeting of the the European Society of Human Reproduction and Embryology. Study authors reported There is “little evidence” that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of breast and gynecological cancers, according to the results of a substantial 30-year follow-up study.
Omega Family Global´s Dr. Kramer says the results are reassuring and a study of such long duration and size lend credibility to the findings.